Surrogate outcomes for clinical trials: Use with caution

Archives of Ophthalmology

Volumn 119, Issue 4, 2001, Pages 576-578

  Chew, E Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RATING SCALE; REPRODUCIBILITY; RETINA MACULA EDEMA; RISK FACTOR; STATISTICAL ANALYSIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0035070704     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.119.4.576     Document Type: Editorial

References (11)

1. How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin Epidemiologic Study of Diabetic Retinopathy
2. Early photocoagulation for diabetic retinopathy: ETDRS report No. 9
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
4. The progression of retinopathy over 2 years: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
5. How effective are treatments for diabetic retinopathy?
6. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study report No. 18
7. A regulatory authority's opinion about surrogate endpoints
8. Surrogate endpoints
9. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS report No. 7
10. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus
11. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)